EUPATI Spain and EURORDIS have implemented a patient engagement model in health product research and development (R and the main issue to improve was “Meeting Organization and Structure”. Overall, the results were favorable. Although the closed-ended questions showed less confidence among CAB members on the future influence of the meetings, the comments from the open-ended questions reflected higher levels of agreement and collaboration and supported our CAB model’s potential. Some issues, mainly related to meeting organization and the hybrid format, need improvement. Future studies are required to assess the actual impact of CAB meetings on companies’ actions.
Camp et al. (Fri,) studied this question.